Sat Kartar Life — 360° view

Sat Kartar Life, a company in the Pharmaceuticals industry, reported revenue of ₹106 crore and net profit of ₹9.00 crore for the September 2026 quarter.

Sat Kartar Life (NSE: SATKARTAR-SM) closed at ₹150.00 on 20 Nov 2026. Its market capitalisation is ₹237 crore and it trades at 12.5 times earnings.

Share price
₹150.00 (20 Nov 2026)
Market cap
₹237 Cr (20 Nov 2026)
P/E
12.50 (20 Nov 2026)
Revenue
₹106 Cr (September 2026 quarter)
Net profit
₹9 Cr (September 2026 quarter)
ROCE
35.8% (FY26)
ROE
26.7% (FY26)
Book value
₹55.3 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹209.95 / ₹110.30 (20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: SATKARTAR-SM

Incorporated in June 2012, Sat Kartar Shopping Limited is an Ayurveda healthcare company that delivers natural wellness solutions for therapeutic and lifestyle products.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.